MedBioSphere
Articles Videos The Web  
    

Search Results lactamase inhibitor

1. Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor.
...commercialization of Novexel's novel intravenous beta lactamase inhibitor, NXL 104 in combination with Forest's ceftaroline...including MRSA, with the addition of the beta lactamase inhibitor NXL 104, we will have achieved the premier, broad...
January 22, 2008; PR Newswire

2. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against Gram negative bacteria
...of three commercially available beta-lactam/beta-lactamase inhibitor combinations (piperacillin/tazobactam, cefoperazone...of three commercially available beta-lactam/beta-lactamase inhibitor combinations: piperacillin/tazobactam (P/T), cefoperazone...
November 1, 2005; Indian Journal of Medical Research

3. MethylGene Regains Exclusive Rights to Beta-Lactamase Inhibitor Program from Merck.
...agreement will be effective 90 days from today. As a result, MethylGene will regain exclusive rights to its beta-lactamase inhibitor program to overcome beta-lactamase mediated antibiotic resistance. We believe Merck has invested significant resources...
August 1, 2007; Canadian Corporate News

4. MethylGene Regains Exclusive Rights to Beta-Lactamase Inhibitor Program from Merck
...agreement will be effective 90 days from today. As a result, MethylGene will regain exclusive rights to its beta- lactamase inhibitor program to overcome beta-lactamase mediated antibiotic resistance. "We believe Merck has invested significant...
August 1, 2007; CCNMatthews Newswire

5. Beating bacteria. (Patents).(GlaxoSmith Kline (US) develops beta-lactamase inhibitor for antibiotics)(Brief Article)
...this problem. GSK has developed a tablet that suppresses the action of [beta]-lactamase. By including this [beta]-lactamase inhibitor with the antibiotic amoxycillin, the company hopes to breathe new life into the embattled drug. European patent...
October 21, 2002; Chemistry and Industry

6. Parenteral beta-lactamase inhibitor combinations for clinical use.
Beta-lactamase enzymes are commonly produced by staphylococci, the Enterobacteriaceae, Pseudomonas aeruginosa and certain anaerobic organisms, such as Bacteroides. fragilis The production of beta lactamases is an important mechanism through which bacteria become resistant to antibiotics. The
May 15, 1995; American Family Physician

7. nces Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections.
...Novexel's broad spectrum beta-lactamase inhibitor, NXL104, with the well established...based around our novel beta-lactamase inhibitor, NXL104, has the potential...injectable non beta lactam, beta-lactamase inhibitor, which is being developed...
November 12, 2008; PR Newswire Europe

8. GlaxoSmithKline Japan to Markey New Acute Otitis Media Drug Clavamox Dry Syrup
...GlaxoSmithKline (GSK) has launched prescription drug Clavamox Dry Syrup in Japan. A penicillin antibiotic with beta-lactamase inhibitor, the new drug is indicated for the treatment of acute otitis media. It can exert beneficial effects with twice...
January 19, 2006; JCNN News Summaries - Japan Corporate News Network

9. Making tablets. (Patents).(Biochemie Gesellschaft develops pharmaceutical tablet making method)(Brief Article)
...lactam antibiotic and a [beta]-lactamase inhibitor, which mean that bacteria...20, 13). But, the [beta]-lactamase inhibitor is highly moisture sensitive...combined with the [beta]-lactamase inhibitor and simply pressed into tablets...
March 3, 2003; Chemistry and Industry

10. New Jersey Inventor Develops Antibiotic Polymers
...beta-lactam antibiotic (e.g., amoxicillin) and a beta-lactamase inhibitor (e.g., clavulanic acid) (or a pharmaceutically...combination of a beta-lactam antibiotic and a beta-lactamase inhibitor (or a pharmaceutically acceptable salt thereof...
July 25, 2008; US Fed News Service, Including US State News